General Information

# Company’s Milestone Company Level 1

 General Information

# Company Vision
To become an integrated corporation in health sector and
capable to generate the sustainable value growth through
synergic business configuration and coordination.
# Company Mission
To generate corporate value growth through activities in the
following sectors:
1. Chemical and pharmaceutical industries based on research
and development of innovative products.
2. Trading and distribution network.
3. Medical services based on retail pharmacy network and other
medical service network.
4. Management of assets associated with the company business
development.
# Vision and Mission Company Level 2
General Information

nnovative
Thinking out of the boxes, smart, and creative to produce leading
products.

ustomer First
Priority on customers as a working partner.

ccountable
Strongly uphold the Company’s trust by hold professionalism, integrity
and cooperation.
esponsible
Have personal responsibility to work on time and on target, and
continually seeks to stand firm and wise in facing any problem.

co-Friendly
Build environmentally friendly systems and behavior.

# Corporate Culture Company Level 3

General Information

# Bussines Sector, Activities & Area Company Level 4

General Information

# Manufactur Company Level 5

General Information
Composition of the Company’s based on employee status in
2013 and 2014 as follows:

Composition of employees :

# Employee Company Level 6

 Strategic Business

Development of Development of Construction of Hospital

Biotechnology
a. Skin Culture
Skin culture was used for the
treatment of burns.
b. Stem Cell
Stem cell was used for treatment
utilizing stem cells, including for
cell bank services.
Establishment of Kimia
Farma Pharmacy in
Malaysia
In cooperation with Averroes
Pharmaceutical, Sdn, Bhd. The
Company established KF-Averroes
Pharmacy in Malaysia.
Radiopharmaceutical
In the utilization of radioisotopes The feasibility study for
technology to diagnose and to construction of Kimia Farma
cure cancer, the Company Hospital was already managed.
Cooperated with Pusat
Radioisotop dan Radiofarmaka
(PRR) Batan
Research & Development Development of Chemical
(R&D) Product
 ARV line 2 amounted to 6 Iodine dan turunannya, dengan
products. pengembangan eksplorasi dan
FDC for TB line 2 amounted to 4 eksploitasi tambang Iodine di
products Jombang dan Mojokerto.
 Generic amounted to 15 Ferrous Sulphate.
products Castor Oil.
Ethical amounted to 16 products Vegetable Oil
OTC amounted to 9 products.

Company Level 7
 Company Performance

148,17% Stock market capitalization increased by 148.17%, from IDR3.28 trillion in

2013 to IDR8,14 trillion in 2014.

20,08% Asset increased by 20.08%, from IDR2.47 trillion in 2013 to IDR2.97

trillion in 2014.

16,58% Operational profit increased by 16,58%, from IDR293,77 billion in 2013 to

IDR342,48 billion in 2014.

09,36% Net profit increased by 9.36%, from IDR214.55 billion in 2013 to

IDR234.63 billion in 2014, which exceeded the Budget by 0.51%.

45,47% Cash increased by 45.47%, from IDR394.15 billion in 2013 to IDR573.36

billion in 2014.

03,98% Sales increased by 3.98%, from IDR4.35 trillion in 2013 to IDR4.52 trillion
in2014, which achieved 87.7% of the Budget.

Company Level 8